Lot No. LOT-3390 · offered November 19, 2026
Agricultural PolicyLot sheet
EU Gene-Editing Rules Apply From July 2028 — Breeders Face a 20-Nucleotide Test
Regulation (EU) 2026/1388 applies from 17 July 2028, splitting NGT plants into two categories. Deletions face no size limit, and trait exclusions — not nucleotide counts — may decide what reaches farmers.
Market notes
- Regulation (EU) 2026/1388 was adopted 17 June 2026 and applies from 17 July 2028
- Category 1 allows substitutions/insertions up to 20 nucleotides but imposes no size limit on deletions
- Herbicide tolerance and known insecticidal traits are excluded from Category 1 regardless of edit size
- A 2026 tomato study with 420 guide RNAs found nearly half of mutations were 1-base changes or deletions of 4 bases or fewer
- Intended herbicide tolerance in rice required a 2-nucleotide prime edit, yet falls outside Category 1 by trait

Regulation (EU) 2026/1388, adopted on 17 June 2026 and applying from 17 July 2028, will decide which gene-edited varieties European farmers can grow — and the rule is more complicated than the "20 nucleotides" shorthand suggests. Until the application date, targeted mutagenesis and cisgenesis remain under the existing EU GMO legislation. A Seed World analysis tracing the sector to 2045 lays out what the framework changes for breeders, seed companies and, ultimately, growers.
The regulation creates two routes. Category 1 covers NGT plants meeting equivalence criteria for modifications comparable to those arising naturally or through conventional breeding. Category 2 covers everything outside those criteria and imposes a heavier pathway. It is a profound departure from the post-2018 regime, when the Court of Justice of the European Union ruled on 25 July 2018 that newer mutagenesis techniques fell under the GMO Directive.
What does the 20-nucleotide rule actually say?
Annex I does not simply impose a 20-nucleotide ceiling. The details matter:
- Substitutions and insertions are limited to 20 nucleotides.
- Deletions face no size limit — a multi-thousand-base deletion is not excluded merely for its size.
- A maximum of three modifications per protein-coding sequence applies, with introns and regulatory sequences treated differently.
- An overall ceiling of 20 modifications per monoploid genome applies.
- Intended herbicide tolerance and production of a known insecticidal substance are excluded from Category 1 regardless of edit size.
The counterintuitive result: a 21-nucleotide insertion hits a boundary while a large deletion may not. Biological significance and regulatory classification are not proportional to the number of DNA letters changed.
How small can a useful edit be?
Research examples show single letters carrying real agronomic weight. In tomato, inserting one nucleotide disrupted a susceptibility gene and sharply restricted tomato yellow leaf curl virus. In rice, a 12-base deletion created broad resistance to several fungal and bacterial diseases while avoiding the yield loss of a larger natural mutation in the same gene. In wheat, a 36-base deletion plus a one-base insertion reduced free asparagine in grain, targeting lower acrylamide formation in high-temperature processing — the deletion exceeds 20 bases but remains eligible in principle.
A 2026 tomato study using 420 guide RNAs targeting 137 genes found almost half of observed mutations were single-base insertions or deletions of four bases or fewer. That documents how common very small changes are, though it does not establish what share of commercially useful edits will qualify for Category 1. These are research examples, not regulatory predictions; each case requires full assessment.
Is the edit the hard part?
Increasingly, no. The analysis argues that knowing what to edit — the pathway, the allele, the consequences — is the scarcer capability, especially for complex traits such as yield stability, drought tolerance and nitrogen use efficiency. Transformation and regeneration remain bottlenecks in many crops; tissue-culture-free approaches, meristem targeting, germline editing and viral delivery may loosen that constraint. And molecular precision does not remove the need for phenotyping, field trials and selection. Agriculture happens in fields, not DNA sequence files.
The toolbox itself has moved well beyond the original "molecular scissors": base editing changes single nucleotides without a double-strand break, prime editing performs genetic "search and replace", and multiplex systems edit several targets at once. A 2025 Nature Plants perspective argues editing will increasingly generate structural variations — insertions, duplications, inversions, translocations — resembling natural crop evolution.
What does this change for the seed trade?
The biology of a plant does not change at a border, but its legal identity can. Countries diverge sharply: some focus on whether foreign DNA remains, others distinguish types of targeted changes or rely on broader GMO frameworks. A breeder developing one variety for several markets must assess how each edit will be classified everywhere it will travel. Trade becomes difficult when an edited crop is conventional in the exporting country and differently categorised at destination. The risk, the analysis warns, is that breeders choose molecular solutions to fit the regulatory map rather than for biological merit. By 2045, regulatory interoperability may matter as much as any gain in Cas efficiency.
The sector itself may grow more layered than larger. Smaller vegetable breeders may outsource editing; technology firms may build delivery systems across elite genotypes; public institutes may discover alleles that commercial breeders deploy. Cheap editing is not cheap product development — germplasm, phenotyping, regulatory expertise, seed multiplication and market development all remain costs of doing business.
Farmers are the final test. Regulatory approval is not adoption, and growers do not buy CRISPR; they buy varieties that yield, stand, resist disease and make economic sense. The author's preferred future headline reads: "First NGT varieties approved smoothly across the EU; farmers embrace new tools." By 2045, success may look like gene editing no longer being discussed as a separate activity at all — simply one tool among crossing, genomic selection and speed breeding in the breeder's programme.
via seedworld.com (Source)
More from Marcus Bennett
Show full bio
Senior reporter covering regulation, policy and their impact on Agribusiness coverage for industry professionals at Agribusiness Wire.
496 articles
Also in the yard
- World Seed Congress Delegates Address Trade Disruptions and Genetics
- Europe's Crop Protection Reform Faces Its First Field Tests
- Europe's Crop Protection Reform Will Be Judged in the Field
- Seed Industry Targets 10% of Global Seed Trade by 2035
- Omnibus X Doubt Clouds Farmers' Access to Biological Crop Protection